What types of policy changes does Blue Shield of California issue?

Blue Shield of California regularly publishes coverage updates including prior authorization requirement changes, billing code additions or deletions, plan-type coverage modifications, and clinical policy revisions. PolicyChanges.app monitors these notices and summarizes the impact for providers.

How often does Blue Shield of California update its policies?

Blue Shield of California typically releases policy bulletins on a rolling basis throughout the year. Our system checks for new updates daily and adds them to this feed as soon as they are identified.

How many Blue Shield of California policy changes are tracked here?

This page currently tracks 50 documented Blue Shield of California policy changes. New items are added as they are identified.

What should I do when Blue Shield of California changes a prior authorization policy?

Review each change's effective date and action-required notes. Update your billing and clinical workflows before the effective date to avoid claim denials. Each policy detail page on PolicyChanges.app includes a plain-English summary and action items.

Blue Shield of California Policy Changes 2026 | Prior Auth & Coverage Updates

Blue Shield of California Policy Changes & Prior Auth Updates

We track 50 documented policy changes from Blue Shield of California across CA. Each entry includes an AI-generated plain-English summary, effective date, affected billing codes, and a direct link to the original Blue Shield of California notice. Use the related links below to narrow results by specialty or state, or sign up for a free daily alert to receive new Blue Shield of California updates automatically.

Medium impact

Surgical Treatment of Snoring and Obstructive Sleep Apnea Syndrome (7.01.101)

Blue Shield of California·Effective Aug 1, 2026

Blue Shield of California updated its surgical treatment policy for obstructive sleep apnea (OSA) and snoring, effective August 1, 2026. The policy establishes specific medical necessity criteria for multiple surgical procedures including palatopharyngoplasty, hypoglossal nerve stimulation, hyoid suspension, mandibular-maxillary advancement, and adenotonsillectomy, while classifying several minimally invasive techniques (laser-assisted palatoplasty, radiofrequency tissue reduction, palatal stiffening procedures) as investigational. Billing teams must ensure prior authorization processes align with these updated criteria and investigational procedure classifications.

Orthognathic Surgery (BSC7.03)

Hematopoietic Cell Transplantation for Autoimmune Diseases (8.01.25)

Cosmetic and Reconstructive Procedures (BSC7.08)

Evaluation of Cerebrospinal fluid, Urine, and Plasma Tests for Alzheimer Disease (2.04.14)

Circulating Tumor-Tissue-Modified Viral DNA Testing for Cancer Management (2.04.160)

Place of Service Policy for Outpatient Procedures (BSC10.01)

Continuous Passive Motion in the Home Setting (1.01.10)

Physical Therapy (BSC8.03)

Investigational Services (BSC9.01)

Prostate Artery Embolization for Benign Prostatic Hyperplasia (7.01.55)

Surgical Treatment of Snoring and Obstructive Sleep Apnea Syndrome (7.01.101)

Skeletal Remodeling (BSC7.21)

Ambulatory Event Monitors and Mobile Cardiac Outpatient Telemetry (2.02.08)

Ablation of Peripheral Nerves to Treat Pain (7.01.154)

Genetic Biomarker Testing (Including Liquid Biopsy) for Targeted Treatment in Advanced Cancer (2.04.151)

Genetic Testing for Duchenne and Becker Muscular Dystrophy (2.04.86)

Electroconvulsive Therapy (BSC8.09)

Applied Behavioral Analysis for Autism Spectrum Disorder or Pervasive Developmental Disorder (BSC3.01)

Transcranial Magnetic Stimulation (BSC2.19)

Comprehensive Genetic Profiling for Selecting Targeted Cancer Therapies (2.04.115)

Germline Genetic Testing for Hereditary Breast/Ovarian Cancer Syndrome and Other High-Risk Cancers (BRCA1, BRCA2, PALB2) (2.04.02)

Genetic Testing for Marfan Syndrome, Thoracic Aortic Aneurysms and Dissections, and Related Disorders (2.04.129)

Continuous Glucose Monitoring (1.01.20)

Noninvasive Fetal RHD Genotyping Using Cell-Free Fetal DNA (2.04.108)

Genetic Cancer Susceptibility Panels Using Next Generation Sequencing (2.04.93)

Remote Electrical Neuromodulation for Migraines (7.01.171)

Identification of Microorganisms Using Nucleic Acid Probes (2.04.10)

Whole Exome and Whole Genome Sequencing for Diagnosis of Genetic Disorders (2.04.102)

Genetic Testing for FMR1 Variants (Including Fragile X Syndrome) (2.04.83)

Renal Denervation for Uncontrolled Hypertension (7.01.136)

Carrier Screening for Genetic Diseases (2.04.107)

Somatic Biomarker Testing (Including Liquid Biopsy) for Targeted Treatment in Non-Small-Cell Lung Cancer (EGFR, ALK, BRAF, ROS1, RET, MET, KRAS, NTRK) (2.04.45)

Noninvasive Techniques for the Evaluation and Monitoring of Patients With Chronic Liver Disease (2.04.41)

Gene Expression Profiling for Cutaneous Melanoma (2.04.146)

Behavioral Health Treatment for Autism Spectrum Disorder or Pervasive Developmental Disorder (BSC3.01)

Genetic Testing for Heterozygous Familial Hypercholesterolemia (2.04.139)

Compression Pumps for Treatment of Lymphedema and Venous Ulcers (1.01.18)

Gene Expression Profile Testing and Circulating Tumor DNA Testing for Predicting Recurrence in Colon Cancer (2.04.61)

Genetic Testing for Hereditary Hearing Loss (2.04.87)

Liposuction for Lipedema and Lymphedema (7.01.169)

Multibiomarker Disease Activity Blood Test for Rheumatoid Arthritis (2.04.119)

Chromosomal Microarray Testing for the Evaluation of Pregnancy Loss (2.04.122)

Molecular Testing in the Management of Pulmonary Nodules (2.04.142)

Repetitive Transcranial Magnetic Stimulation as a Treatment of Depression and Other Psychiatric/Neurologic Disorders (BSC2.19)

Power Wheelchairs and Power Operated Vehicles for Permanent Use (BSC1.02)

Leadless Cardiac Pacemakers (2.02.32)

Transcatheter Tricuspid Valve Repair or Replacement (2.02.34)

Balloon Spacers for Treatment of Irreparable Rotator Cuffs of the Shoulder (7.01.180)

Tibial Nerve Stimulation (7.01.106)

Baroreflex Stimulation Devices (8.01.57)